02 December 2016

Notice of Half Year Results
Analyst Briefing

The Board of Collagen Solutions plc (AIM: COS), the developer and manufacturer of medical grade collagen components for use in regenerative medicine, medical devices and in-vitro diagnostics, will announce their unaudited interim results for the six months ending 30 September 2016 on Monday, 19 December 2016.

A briefing for analysts will take place at Walbrook PR, 4 Lombard Street, London EC3V 9HD at 10.00am on Monday 19 December 2016.

If you would like to register to attend the briefing, or require further information, please contact Walbrook PR on 020 7933 8780 or email collagen@walbrookpr.com.

 

Enquiries:

Collagen Solutions Plc Contact via Walbrook
Jamal Rushdy, Chief Executive Officer 
Gill Black, Chief Financial Officer  
   
Cenkos Securities plc (Nominated Adviser & Broker) Tel: 0207 397 8900
Stephen Keys  
Steve Cox  
   
Walbrook PR Ltd Tel: 020 7933 8780 or collagen@walbrookpr.com
Mike Wort Mob: 07900 608 002
Anna Dunphy Mob: 07876 741 001